哪些因素阻碍癌症女性考虑生育力保留治疗时的决策过程
本叙述性综述系统检索2005年1月1日至2016年1月底的医学与社会科学文献,纳入46篇定量、定性与混合方法研究,分析癌症女性在考虑生育力保留(FP)治疗时决策受阻的因素。分析得出6个关键主题及15个亚主题,涉及信息提供、对风险的恐惧、肿瘤科未转诊、两难困境、个人状况与费用。作者认为决策支持干预、循证信息与培训项目可能有益,并建议进一步研究预后及道德伦理宗教信念的影响。
要点
- 阻碍FP决策的因素包括信息缺乏与时机不当、医患沟通不足等外部服务问题。
- 女性对FP相关风险的恐惧常被高估且缺乏证据基础,也阻碍决策。
- 肿瘤科未转诊至生育门诊与费用担忧是影响决策的重要障碍。
核心结论
- 广泛的内外部因素影响癌症女性的FP决策过程,外部问题主要涉及服务提供与转诊,内部问题包括女性对FP风险的恐惧,而这些风险通常被高估且缺乏证据基础。
- 作者认为实施决策支持干预、提供更多循证FP信息(理想在癌症诊断时、见生育专家前获得)以及针对沟通技能的培训项目可能有益。
- 作者认为预后较差以及道德、伦理和宗教信仰对FP决策的影响值得进一步研究。
研究设计与样本
- 叙述性综述,系统检索2005年1月1日至2016年1月底Web of Science(PubMed)、Ovid SP Medline和CINAHL via Ebsco三个电子数据库的医学与社会科学文献,并手工检索相关论文参考文献。
- 纳入定量、定性与混合方法研究,从983篇文献中纳入46篇;使用混合方法评价工具进行质量评估,采用主题分析分析数据。
主要发现
- 分析得出6个关键主题及15个亚主题:生育信息提供(信息缺乏、信息时机、医患沟通);对追求FP相关风险的恐惧(延迟癌症治疗、加重激素阳性癌症、未来妊娠的后果);肿瘤科未转诊(个人情况、激素阳性癌症、FP非优先事项、服务衔接问题);两难困境(处于生存模式、是否优先一种治疗);个人情况(产次、关系状态);费用(经济担忧)。
临床怎么用
- 作者认为在FP与癌症临床照护路径中实施一系列决策支持干预可能有益。
- 作者认为女性可能受益于在癌症诊断时、见生育专家前获得更多循证FP信息,例如通过实施患者决策辅助工具。
- 作者认为肿瘤与生育服务的医疗专业人员可能受益于实施培训项目和教育工具,以改善协作决策与以患者为中心的照护。
局限性
- 作者认为预后较差以及道德、伦理和宗教信仰对FP决策过程的影响程度值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although fertility preservation (FP) treatment options have increased, the existing evidence suggests that many women with cancer do not feel well supported in making these decisions, but find them stressful and complex and fail to take up fertility care at this crucial time. Whilst existing reviews have all made important contributions to our understanding of the FP decision-making process, none of them examine solely and specifically these processes for women of reproductive age with a diagnosis of any cancer, leaving a gap in the knowledge base. Given the expectation that care is patient-centred, our review aims to address this gap which may be of help to those managing patients struggling to make difficult decisions in the often brief period before potentially sterilizing cancer treatment is started. OBJECTIVE AND RATIONALE: Underpinning this narrative review was the question 'What factors hinder the decision-making process for women with any cancer and contemplating FP treatment?' Our objectives were to (i) assess and summarize this existing literature, (ii) identify the factors that hinder this decision-making process, (iii) explore to what extent these factors may differ for women choosing different methods of FP and (iv) make recommendations for service delivery and future research. SEARCH METHODS: A systematic search of the medical and social science literature from the 1 January 2005 up to the end of January 2016 was carried out using three electronic databases (Web of Science (PubMed), Ovid SP Medline and CINAHL via Ebsco). Included in the review were quantitative, qualitative and mixed-method studies. Reference lists of relevant papers were also hand searched. From the 983 papers identified, 46 papers were included. Quality assessment was undertaken using the Mixed Methods Appraisal Tool and thematic analysis was used to analyse the data. OUTCOMES: From the analysis, 6 key themes with 15 sub-themes emerged: (i) fertility information provision (lack of information, timing of the information, patient-provider communication); (ii) fear concerning the perceived risks associated with pursuing FP (delaying cancer treatment, aggravating a hormone positive cancer and consequences of a future pregnancy); (iii) non-referral from oncology (personal situation, having a hormone positive cancer, FP not a priority and transition between service issues); (iv) the dilemma (in survival mode, whether to prioritize one treatment over another); (v) personal situation (parity, relationship status) and (iv) costs (financial concerns). WIDER IMPLICATIONS: This review has found that a wide range of internal and external factors impact the FP decision-making process. Key external issues related to current service delivery such as the provision and timing of FP information, and lack of referral from oncology to the fertility clinic. However, internal issues such as women's fears concerning the perceived risks associated with pursuing FP also hindered decision-making but these 'risks' were typically overestimated and non-evidence based. These findings suggest that the implementation of a range of decision support interventions may be of benefit within the clinical care pathway of FP and cancer. Women would benefit from the provision of more evidence-based FP information, ideally received at cancer diagnosis, in advance of seeing a fertility specialist, for example through the implementation of patient decision aids. Healthcare professionals in both oncology and fertility services may also benefit from the implementation of training programmes and educational tools targeted at improving the communication skills needed to improve collaborative decision-making and deliver care that is patient-centred. Exploration of the current barriers, both intellectual and practical, that prevent some patients from accepting FP will help care providers to do better for their patients in the future. Finally, the extent to which a poorer prognosis and moral, ethical and religious beliefs influence the FP decision-making process also warrant further research.
引用
- Jones G, Hughes J, Mahmoodi N, et al. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017. PMID: 28510760. doi:10.1093/humupd/dmx009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。